RELATED STUDY
Key Findings:
Type of Study:
Study Result: Inconclusive
Research Location(s):
Year of Pub:
Cannabinoids Studied:
Chemotype:
Terpenes Studied:
Receptors Studied:
Ligands Studied:
DOSING DETAILS 
Study Dosing Objective: Effective Dose
Established Protocol: No effective dose
Route of Administration:
Cannabinoid Ratio: (CBD) 0 
Dosing Regimen: CBD (10 mg) or placebo 2x daily
Treatment Duration: 8 weeks
Clinical Relevance: For Crohn's disease, CBD was safe but had no beneficial effects.
Adverse Events: No side effects were observed.
Citation:
